Advancing Pediatric ADHD Treatment: Spray-Dried Atomoxetine Microparticles for Extended-Release Therapy
Overview
Attention-deficit/hyperactivity disorder (ADHD) affects 1 in 9 children in the United States. Current stimulant medications carry risks of elevated blood pressure, heart rate, and potential for abuse. While non-stimulants like atomoxetine offer a safer alternative, this drug is only available as an immediate-release formulation, necessitating redosing and leading to poor patient adherence. This project formulated spray-dried atomoxetine microparticles using a taste-masking polymer matrix for extended release. The polymers hydroxypropyl methylcellulose acetate succinate (HPMCAS), Eudragit S100, and beta-cyclodextrin were chosen. An eight-run extreme vertices mixture design of experiments was created to study the optimal polymer ratio. Batches were formulated from atomoxetine hydrochloride-polymer suspensions (5% w/w drug loading) using a Buchi spray-dryer. Drug release from the microparticles of all eight batches was studied in dialysis bags in simulated gastric fluid for the first 2 hours and intestinal fluid for the remainder of the 24-hour study. Samples taken at 1, 2, 4, 6, and 24 hours were analyzed via UV-Vis. Analysis of drug release data and spray-drying yield showed that a polymer ratio of 70% HPMCAS, 20% Eudragit S100, and 10% beta-cyclodextrin was optimal. This batch released approximately 60% of the drug by 2 hours and 95% by 24 hours, demonstrating extended release. Scanning electron microscopy showed an average particle size of 1-5 µm, while a colorimetric assay approximated entrapment efficiency at 103% w/w. These findings suggest that spray-dried atomoxetine microparticles can provide a non-stimulant alternative to current ADHD medications, potentially improving safety, dosing frequency, and compliance among pediatric patients.
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2025
Optimizing Drug Release From Encapsulated Pills for the Potential of Steadier Efficacy
ISEF · 2025
Advancing Opioid Overdose Intervention: Formulating Novel Spray-Dried Naloxone Microparticles for Pulmonary Delivery
ISEF · 2022
The Effect of Polymer Coating on Taste-Masking Ability of AZT (HIV Drug) for Pediatric Oral Delivery
ISEF · 2026
HyperPhase DuoTab - A Dual-Drug Biphasic Release System for Personalized Hypertension Management
ISEF · 2026
3D-Printed Buccal Films for Transmucosal Antidepressant Delivery and Personalized Dose Tapering
CSEF · 2018
On-Demand Electrically Controlled Drug Release from Resorbable Nanocomposite Films
CSEF · 2017
Analysis of Novel Carboxymethyl Chitosan/Sodium Alginate Microspheres as a Potential Drug Delivery System
ISEF · 2026
Evaluating Behavioral Outcomes and Gut Microbiome Diversity in Drosophila melanogaster Following Exposure to Natural Versus Prescription ADHD Interventions
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair